Investing Profile

Andrew Sinclair

InvestorVC

Partner, Portfolio Manager at Abingworth

Photo of Andrew Sinclair, Partner at Abingworth

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Abingworth Partner
$15.0M - $30.0M
$22.5M
1
CompanyStageDateRound SizeTotal Raised
Soleno Therapeutics
Post-IPO EquityDec 2018$16.5M
$16.5M